Vanda Pharmaceuticals
VNDA
#7377
Rank
NZ$0.53 B
Marketcap
$9.11
Share price
1.12%
Change (1 day)
57.48%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -NZ$53.36 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.18 Billion. In 2023 the company made an earning of -NZ$23.54 Million a decrease over its 2022 earnings that were of NZ$10.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$53.36 Million126.64%
2023 -NZ$23.54 Million-320.45%
2022 NZ$10.67 M-84.99%
2021 NZ$71.14 M54.8%
2020 NZ$45.95 M19.42%
2019 NZ$38.48 M4.93%
2018 NZ$36.67 M-228.6%
2017 -NZ$28.52 Million-8.98%
2016 -NZ$31.34 Million-53.79%
2015 -NZ$67.81 Million-30.18%
2014 -NZ$97.11 Million173.08%
2013 -NZ$35.56 Million-25.33%
2012 -NZ$47.63 Million163.61%
2011 -NZ$18.07 Million-221.15%
2010 NZ$14.91 M-124.53%
2009 -NZ$60.8 Million-29.44%
2008 -NZ$86.16 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$40.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$21.48 B-39,311.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$17.12 B-31,361.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.03 B-56,752.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.61 Billion 21,088.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.05 Billion 3,632.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$9.22 Million-83.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$27.82 B-50,885.34%๐Ÿ‡บ๐Ÿ‡ธ USA